The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Human ...
16 Luglio 2012 - 6:18PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Human Genome Sciences, Inc. (“Human Genome” or the “Company”)
(NasdaqGS: HGSI) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to GlaxoSmithKline plc.
Click here to learn more about the investigation:
http://zlk.9nl.com/human-genome, or call: 877-363-5972.
There is no cost or obligation to you.
Under the terms of the transaction, Human Genome shareholders
will receive $14.25 per share of Human Genome stock they own. The
transaction has a total approximate value of $3 billion. The
investigation concerns whether the Human Genome Board of Directors
breached their fiduciary duties to stockholders by failing to
adequately shop the Company before entering into this transaction
and whether GlaxoSmithKline is underpaying for Human Genome shares,
thus unlawfully harming Human Genome stockholders. In particular,
at least one analyst set a price target for Human Genome stock at
$23.00 per share.
If you own common stock in Human Genome and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/human-genome.
Levi & Korsinsky is a national firm with offices in New York
and Washington D.C. The firm has extensive expertise in prosecuting
securities litigation involving financial fraud, representing
investors throughout the nation in securities and shareholder
lawsuits. The attorneys at Levi & Korsinsky have been appointed
by numerous courts throughout the country to serve as lead counsel
on behalf of shareholders in major securities lawsuits and have
successfully recovered multimillion-dollar damages awards on behalf
of investors. For more information, please feel free to contact any
of the attorneys listed below. Attorney advertising. Prior results
do not guarantee similar outcomes.
Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Human Genome Sciences, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Levi & Korsinsky, LLP Articoli Notizie